New MRI scans aim to unlock secrets of lung disease and long COVID
NCT ID NCT04872309
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study uses special MRI scans with inhaled gases to see how lungs work in people with asthma, COPD, or COVID-19. Researchers will follow up to 160 participants over several years to track changes in lung function. The goal is to better understand why some patients struggle with oxygen therapy and whether COVID-19 causes lasting lung damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could improve how doctors track lung disease progression and understand long-term effects of COVID-19.
- What could go wrong
- This is an observational imaging study, not a treatment trial. It is currently suspended, and results may not lead to immediate clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Academic Unit of Radiology, Univeristy of Sheffield
Sheffield, South Yorkshire, S10 2SJ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking severe asthma over time unlock better treatments?
- Five years on: how does long COVID evolve?
- Could exercise retrain the heart in long COVID?
- Blood test may curb antibiotic overuse in COPD attacks
- Can pressurized breathing boost mucus clearance in lung disease?
- HIV and hidden health risks: a major study probes the link